Carocell Bio
Chester
About Carocell Bio
Bridge is an ambitious company aiming to be revenue-generating within 5 years by taking the lead project to exit, via out-licensing or trade sale, by investing in the innovative programs to treat serious inflammatory disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Mar 2021)
- Website: carocellbio.com
- Phone: +44 (0) 20 3097 1979
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/carocell-bio-2426966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.